New Delhi -°C
Today in New Delhi, India

Oct 23, 2020-Friday
-°C

Humidity
-

Wind
-

Select Country
Select city
ADVERTISEMENT
Home / World News / Endo starts manufacturing Novavax’s potential Covid-19 vaccine

Endo starts manufacturing Novavax’s potential Covid-19 vaccine

The news comes a day after Novavax launched a late-stage trial of the vaccine candidate, NVX-CoV2373, in the United Kingdom.

world Updated: Sep 25, 2020, 17:27 IST
Reuters | Posted by Arpan Rai
Reuters | Posted by Arpan Rai
Signage is displayed outside the Novavax Inc. headquarters in Gaithersburg, Maryland, US.
Signage is displayed outside the Novavax Inc. headquarters in Gaithersburg, Maryland, US. (Bloomberg)

Generic drugmaker Endo said on Friday it was manufacturing Novavax Inc’s experimental Covid-19 vaccine, sending its shares up 10% before the trading bell.

The news comes a day after Novavax launched a late-stage trial of the vaccine candidate, NVX-CoV2373, in the United Kingdom.

Endo said it has signed a deal with Novavax and its unit Par Sterile has begun production of the final drug product, with initial batches to be used in Novavax’s phase-3 clinical trial in the United States.

Financials and other terms of the non-exclusive agreement were not disclosed.

NVX-CoV2373 is currently also being tested in two ongoing mid-stage trials that began in August.

ht epaper

Sign In to continue reading